feed,title,long_url,short_url
Benzinga,GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data,https://benzinga.com/general/biotech/23/11/35954764/gsk-frames-a-comeback-for-its-multiple-myeloma-drug-following-encouraging-phase-3-data,https://da.gd/LyQYG
